SMRUTHI ORGANICS
|
SMRUTHI ORGANICS Last 5 Year Financial Ratios History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 3.11 | 3.14 | 3.61 | 9.07 | 14.95 |
| CEPS(Rs) | 7.92 | 8.08 | 7.60 | 12.79 | 18.39 |
| DPS(Rs) | 1.50 | 1.50 | 2.00 | 3.00 | 3.00 |
| Book NAV/Share(Rs) | 62.58 | 60.82 | 59.55 | 58.68 | 52.85 |
| Tax Rate(%) | 27.29 | 27.76 | 8.07 | 24.62 | 28.88 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 9.58 | 9.04 | 6.90 | 13.80 | 22.56 |
| EBIT Margin(%) | 5.33 | 4.82 | 3.75 | 11.05 | 19.88 |
| Pre Tax Margin(%) | 3.86 | 3.76 | 3.17 | 10.31 | 19.02 |
| PAT Margin (%) | 2.81 | 2.71 | 2.91 | 7.78 | 13.52 |
| Cash Profit Margin (%) | 7.14 | 6.99 | 6.14 | 10.96 | 16.64 |
| Performance Ratios | |||||
| ROA(%) | 3.07 | 3.18 | 4.24 | 11.57 | 19.05 |
| ROE(%) | 5.04 | 5.21 | 6.11 | 16.27 | 33.23 |
| ROCE(%) | 7.98 | 8.22 | 7.39 | 21.00 | 39.08 |
| Asset Turnover(x) | 1.09 | 1.17 | 1.46 | 1.49 | 1.41 |
| Sales/Fixed Asset(x) | 0.94 | 1.05 | 1.20 | 1.21 | 1.20 |
| Working Capital/Sales(x) | 3.94 | 3.97 | 4.75 | 3.62 | 3.84 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 1.07 | 0.95 | 0.83 | 0.83 | 0.84 |
| Receivable days | 105.63 | 107.56 | 84.30 | 68.12 | 66.25 |
| Inventory Days | 83.47 | 74.16 | 56.56 | 52.02 | 50.80 |
| Payable days | 118.73 | 134.43 | 71.26 | 57.14 | 99.35 |
| Valuation Parameters | |||||
| PER(x) | 35.42 | 46.58 | 35.61 | 24.69 | 14.87 |
| PCE(x) | 13.92 | 18.09 | 16.90 | 17.51 | 12.09 |
| Price/Book(x) | 1.76 | 2.40 | 2.16 | 3.82 | 4.21 |
| Yield(%) | 1.36 | 1.03 | 1.56 | 1.34 | 1.35 |
| EV/Net Sales(x) | 1.13 | 1.40 | 1.07 | 1.94 | 1.96 |
| EV/Core EBITDA(x) | 11.61 | 14.82 | 15.27 | 13.60 | 8.54 |
| EV/EBIT(x) | 21.05 | 27.96 | 28.41 | 17.53 | 9.88 |
| EV/CE(x) | 1.61 | 2.19 | 2.05 | 3.70 | 2.71 |
| M Cap / Sales | 1.00 | 1.31 | 1.04 | 1.92 | 2.01 |
| Growth Ratio | |||||
| Net Sales Growth(%) | -1.28 | -9.50 | 5.75 | 5.43 | -3.49 |
| Core EBITDA Growth(%) | 1.99 | 21.67 | -47.99 | -34.65 | 48.00 |
| EBIT Growth(%) | 6.14 | 19.97 | -63.97 | -41.33 | 64.67 |
| PAT Growth(%) | -0.76 | -13.09 | -60.21 | -39.31 | 102.52 |
| EPS Growth(%) | -0.76 | -13.09 | -60.21 | -39.31 | -32.49 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.23 | 0.17 | 0.08 | 0.04 | 0.17 |
| Current Ratio(x) | 2.00 | 1.78 | 1.81 | 3.37 | 2.26 |
| Quick Ratio(x) | 1.12 | 1.08 | 1.16 | 2.09 | 1.57 |
| Interest Cover(x) | 3.62 | 4.53 | 6.46 | 15.00 | 23.00 |
| Total Debt/Mcap(x) | 0.13 | 0.07 | 0.04 | 0.01 | 0.04 |
Compare Financial Ratios of peers of SMRUTHI ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SMRUTHI ORGANICS | ₹146.4 Cr | 2.3% | -1.8% | 6.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹439,378.0 Cr | 2.8% | 6.7% | 2.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,996.0 Cr | 1.9% | -0.5% | 6.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹125,959.0 Cr | 0.1% | 3.4% | 15.8% | Stock Analytics | |
| CIPLA | ₹123,666.0 Cr | 1.8% | -3.2% | 2.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,008.0 Cr | 2.7% | 0.4% | 3.4% | Stock Analytics | |
SMRUTHI ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SMRUTHI ORGANICS | 2.3% |
-1.8% |
6.8% |
| SENSEX | 0.6% |
1.3% |
7% |
You may also like the below Video Courses
